Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 2
2007 2
2008 2
2009 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults.
van der Lugt J, Autar RS, Ubolyam S, Garcia EF, Sankote J, Avihingsanon A, Chuenyam T, Cooper DA, Lange J, Phanuphak P, Wit F, Ruxrungtham K, Burger D; HIV-NAT 019 Study Team. van der Lugt J, et al. Among authors: sankote j. J Antimicrob Chemother. 2008 May;61(5):1145-53. doi: 10.1093/jac/dkn050. Epub 2008 Feb 18. J Antimicrob Chemother. 2008. PMID: 18285316 Clinical Trial.
Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin.
Manosuthi W, Sungkanuparph S, Thakkinstian A, Vibhagool A, Kiertiburanakul S, Rattanasiri S, Prasithsirikul W, Sankote J, Mahanontharit A, Ruxrungtham K. Manosuthi W, et al. Among authors: sankote j. AIDS. 2005 Sep 23;19(14):1481-6. doi: 10.1097/01.aids.0000183630.27665.30. AIDS. 2005. PMID: 16135901 Clinical Trial.
Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-daily.
Autar RS, Ananworanich J, Apateerapong W, Sankote J, Hill A, Hirschel B, Cooper D, Lange J, Phanuphak P, Ruxrungtham K, Burger D. Autar RS, et al. Among authors: sankote j. J Antimicrob Chemother. 2004 Oct;54(4):785-90. doi: 10.1093/jac/dkh415. Epub 2004 Aug 25. J Antimicrob Chemother. 2004. PMID: 15329366 Clinical Trial.
Supersensitive Viral Load Assay in Predicting CD4-Guided Treatment Failure.
Langford S, Gayet-Ageron A, Duncombe C, Jupimai T, Mahanontharit A, Kiertiburanakul S, Munsakul W, Ruxrungtham K, Hirschel B, Ananworanich J; Staccato Study Group. Langford S, et al. Open Virol J. 2008;2:69-73. doi: 10.2174/1874357900802010069. Epub 2008 Oct 16. Open Virol J. 2008. PMID: 19440466 Free PMC article.